A Src-Like Inactive Conformation in the Abl Tyrosine Kinase Domain
2006
Understanding a Key Enzyme's Role in Cancer-Drug Resistance
publication
Evidence: moderate
Author Information
Author(s): Nicholas M. Levinson, Olga Kuchment, John Kuriyan
Hypothesis
Could the Src-like inactive conformation of Abl provide insights into imatinib resistance in chronic myeloid leukemia?
Conclusion
The Src-like inactive conformation of Abl may play a significant role in the effectiveness of imatinib in treating chronic myeloid leukemia.
Supporting Evidence
- The researchers discovered four new forms of the Abl kinase domain.
- They found an unprecedented inactive conformation similar to another kinase called Src.
- Simulations suggested that the Src-like form might help facilitate the DFG flip.
Takeaway
Scientists found a new shape of a protein that might help explain why some cancer treatments don't work.
Methodology
The researchers used crystallography and computer simulations to study the conformations of the Abl kinase domain.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website